Novo Nordisk
Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Their purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.
![Novo Nordisk logo](https://www.thinkgp.com.au/sites/default/files/novonordisk_logo_cmyk_blue_large.jpg)
![Yellow fat like obesity cells](/sites/default/files/styles/home_slideshow/public/field/image/shutterstock_1716463567.jpg?itok=YhAP3hzr)
Events
EA:
1.5
MO:
RP:
Total:
1.5
Live webinar: Residual risk in CVD: Same war, new battle
![Image](/sites/default/files/styles/education_image/public/shutterstock_1849638520.jpg?itok=CaPahTK9)
QI Program
EA:
1.5
MO:
6
RP:
14
Total:
21.5
Diabetes cycle of care quality improvement program (Practice staff version)
![Image](/sites/default/files/styles/education_image/public/shutterstock_1849638520.jpg?itok=CaPahTK9)
QI Program
EA:
1.5
MO:
6
RP:
14
Total:
21.5
Diabetes cycle of care quality improvement program (GP version)
![Image](/sites/default/files/styles/education_image/public/shutterstock_1849638520.jpg?itok=CaPahTK9)
Audits
EA:
1.5
MO:
6
RP:
14
Total:
21.5
Diabetes cycle of care quality improvement program
![Yellow fat like obesity cells](/sites/default/files/field/image/shutterstock_1716463567.jpg)
EA:
1.5
MO:
RP:
Total:
1.5
Live webinar: Residual risk in CVD: Same war, new battle